Moderna’s (MRNA) Stock Falls on Omicron Variant Concerns Posted byZacks Equity Research December 1, 2021 Leave a comment on Moderna’s (MRNA) Stock Falls on Omicron Variant Concerns Moderna (MRNA) shares decline following a two-day rise as the Omicron-variant creates uncertainty with limited data. The next couple of weeks may provide a clearer picture.